Cristoria, Baby Girl .
HRN: 22-33-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2022
AMPICILLIN 250MG (VIAL)
12/20/2022
12/27/2022
IV
130mg
Q12
Potentially Septic Newborn (Thickly Msaf)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes